In a rare display of bipartisanship, key committees of both houses of Congress are backing legislation that would permanently erase the sustainable growth-rate formula, a poorly thought out payment reform measure that for more than a decade dictated sharp cuts in Medicare physician pay.
In a rare display of bipartisanship, key committees of both houses of Congress are backing legislation that would permanently erase the sustainable growth-rate formula, a poorly thought out payment reform measure that for more than a decade dictated sharp cuts in Medicare physician pay. Now all they have to do is figure out how to pay for it.
The usual fix is for Congress to temporarily freeze physician pay for a few months or years. So far, that's cost $150 billion and left physicians facing a nearly 24% pay cut when the latest fix expires, which is March 31.
To pay for its fixes, Congress usually included an across-the-board cut in hospitals' future Medicare reimbursement rates. That approach did nothing to improve quality and eventually leads to seniors being denied needed care.
Read the full story here:http://bit.ly/1dtWvpT
Source: Modern Healthcare
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More